http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP18051972-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
filingDate 2018-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_011aac4978e84efbaf0e72acf8695326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3bcf31b8a1ec8ce3f4aed06b9b81780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01989a5af4aab8007e8534f3462a0b4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_230883e8fe89d2074751514cd6e0358d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b410edfc96d25fc79656aa5f2eabfaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c50b82b82308e264d13ec5a1934d4681
publicationDate 2018-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP18051972-A
titleOfInvention NEW DERIVATIVES OF PHOSPHINANS AND AAPHOSPHINANS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
abstract Compounds of formula (I) (SEE FORMULA IN THE TECHNICAL REPORT) in which: Ak1 represents an alkyl chain, X represents -(CH2)m-, -CH(R)-, -N(R)-, -CH2- N(R)-, -N(R)-CH2- or -CH2-N(R)-CH2-, m and R are as defined in the description, R1 and R2 each represent H when X represents -( CH2)m-, -CH(R)-, -N(R)-, -CH2-N(R)- or –N(R)-CH2-, or together form a bond when X represents -CH2-N (R)-CH2-, R3 represents NH2, Cy-NH2, Cy-Ak3-NH2 or piperidin-4-yl, Cy and Ak3 are as defined in the description, R4 and R5, identical or different, each represent one H or F, their optical isomers, as well as their addition salts to a pharmaceutically acceptable acid. Medicines.
priorityDate 2016-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457517809

Total number of triples: 32.